Thomas Wakim
Stock Analyst at Bell Potter
(0.25)
# 4,578
Out of 5,073 analysts
117
Total ratings
41%
Success rate
-9.8%
Average return
Main Sectors:
Stocks Rated by Thomas Wakim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: CGS Cogstate Limited | Reiterated: Buy | $3.70 → $4.05 | $3.61 | +12.19% | 8 | Oct 19, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Reiterated: Buy | $3.00 → $3.30 | $1.79 | +84.15% | 10 | Oct 7, 2026 | |
| ASX: ALC Alcidion Group Limited | Reiterated: Buy | $0.15 | $0.10 | +54.64% | 16 | Sep 30, 2026 | |
| ASX: IMM Immutep Limited | Reiterated: Hold | $0.07 → $0.06 | $0.02 | +160.87% | 9 | Sep 14, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Downgraded: Hold | $17.00 → $11.50 | $6.93 | +65.95% | 6 | Aug 27, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Reiterated: Buy | $25.50 | $19.41 | +31.38% | 17 | Aug 27, 2026 | |
| ASX: CSL CSL Limited | Reiterated: Hold | $120.00 → $150.00 | $195.17 | -23.14% | 11 | Aug 19, 2026 | |
| ASX: ATX Amplia Therapeutics Limited | Reiterated: Buy | $0.42 | $0.08 | +438.46% | 3 | Aug 5, 2026 | |
| ASX: SNT Syntara Limited | Reiterated: Buy | $0.06 | $0.02 | +215.79% | 7 | Jul 28, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Downgraded: Hold | $0.12 → $0.05 | $0.04 | +25.00% | 13 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $0.55 → $0.10 | $0.09 | +17.65% | 8 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.09 → $0.10 | $0.01 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.30 → $0.05 | $0.01 | n/a | 4 | Apr 1, 2025 |
Cogstate Limited
Oct 19, 2026
Reiterated: Buy
Price Target: $3.70 → $4.05
Current: $3.61
Upside: +12.19%
PYC Therapeutics Limited
Oct 7, 2026
Reiterated: Buy
Price Target: $3.00 → $3.30
Current: $1.79
Upside: +84.15%
Alcidion Group Limited
Sep 30, 2026
Reiterated: Buy
Price Target: $0.15
Current: $0.10
Upside: +54.64%
Immutep Limited
Sep 14, 2026
Reiterated: Hold
Price Target: $0.07 → $0.06
Current: $0.02
Upside: +160.87%
Clinuvel Pharmaceuticals Limited
Aug 27, 2026
Downgraded: Hold
Price Target: $17.00 → $11.50
Current: $6.93
Upside: +65.95%
Neuren Pharmaceuticals Limited
Aug 27, 2026
Reiterated: Buy
Price Target: $25.50
Current: $19.41
Upside: +31.38%
CSL Limited
Aug 19, 2026
Reiterated: Hold
Price Target: $120.00 → $150.00
Current: $195.17
Upside: -23.14%
Amplia Therapeutics Limited
Aug 5, 2026
Reiterated: Buy
Price Target: $0.42
Current: $0.08
Upside: +438.46%
Syntara Limited
Jul 28, 2026
Reiterated: Buy
Price Target: $0.06
Current: $0.02
Upside: +215.79%
Microba Life Sciences Limited
Jul 16, 2026
Downgraded: Hold
Price Target: $0.12 → $0.05
Current: $0.04
Upside: +25.00%
Apr 7, 2026
Downgraded: Hold
Price Target: $0.55 → $0.10
Current: $0.09
Upside: +17.65%
May 13, 2025
Reiterated: Hold
Price Target: $0.09 → $0.10
Current: $0.01
Upside: n/a
Apr 1, 2025
Downgraded: Sell
Price Target: $1.30 → $0.05
Current: $0.01
Upside: n/a